IV

Innovation1 Biotech IncOOTC IVBT Stock Report

Last reporting period 28 Feb, 2023

Updated 01 Nov, 2024

Last price

Market cap $B

0.02

Micro

Exchange

OOTC - OTC

IVBT Stock Analysis

IV

Uncovered

Innovation1 Biotech Inc is uncovered by Eyestock quantitative analysis.

Market cap $B

0.02

Dividend yield

Shares outstanding

20.02 B

Website

Innovation1 Biotech, Inc. is a drug discovery company, which engages in the development of modified Schedule 1 molecules of botanical origin to create derivatives for treatment of neurologic, psychiatric, dermatologic, and ophthalmologic disorders. The company is headquartered in Rockaway, New Jersey. The company went IPO on 2017-02-06. The firm also owns a patented nutraceutical complex, which is designed and formulated to contribute and help in maintaining normal energy metabolism, improve mood and reduce fatigue for those suffering from fibromyalgia and chronic fatigue syndrome. The firm markets its products under the trademark Gridiron BioNutrients and Gridiron MVP, including GridironMVP Alkaline Nutrition with Probiotics, GridironMVP Concentrate, Gridiron CBD Premium Hemp Tinctures, Gridiron CBD Gummies and Gridiron CBD Salve. The company markets its products through its Website www.gridironmvp.com.

View Section: Eyestock Rating